Belgium cuts cancer survivors’ waiting period to five years in 2025

In January 2025, Belgium will implement a significant change to the waiting period for cancer survivors seeking to exercise their 'right to be forgotten.' This period will be reduced from eight years to five, marking a crucial step towards addressing financial discrimination faced by cancer survivors. The change is part of a broader movement across Europe to ensure fair treatment for individuals who have survived cancer, as highlighted by Dr. Françoise Meunier, a prominent advocate for change. Despite this progress, a recent study published in Lancet Oncology indicates that substantial work remains to protect cancer survivors from financial discrimination. Discriminatory practices in loans, mortgages, and insurance policies continue to create barriers for survivors attempting to reintegrate into normal life. Dr. Meunier emphasizes the need for a comprehensive European legal framework to tackle these inequities effectively. Countries like Greece have already begun to address these issues, with the Hellenic Association of Insurance Companies proposing a Code of Conduct to ensure the right to be forgotten for cancer survivors. However, the European Commission has yet to reach a consensus on the appropriate waiting period, with ongoing negotiations among stakeholders. As Belgium prepares for this legislative change, the importance of aligning laws with medical advancements is underscored. The Belgian legislation will be updated every two years to reflect medical progress, ensuring that survivors receive timely protection. Advocates like Dr. Meunier continue to push for stronger European legislation to safeguard the rights of cancer survivors across all financial services.